info@tiba.bio
 

Media CoverageTech Transfer Roundup: Tiba and CEPI Strategize Together On ‘Disease X’

January 25, 2023

This article, appearing in Scrip’s Tech Transfer Roundup, reports on Tiba Biotech and CEPI planning ahead for the next pandemic.  Read more

previous
Coup de pouce majeur pour les vaccins à ARNm ciblant la «maladie X»
next
NIH awards Tiba a Phase II SBIR grant to advance RNA vaccines against pandemic influenza
https://i0.wp.com/tiba.bio/wp-content/uploads/2021/05/Tiba-small-logo2.png?fit=140%2C58&ssl=1
info@tiba.bio
1 Broadway, 14th Fl., Cambridge MA

Keep connected with us

Check out our careers page
See what we are doing!

© 2024 Tiba Biotech LLC. All rights reserved

Terms and Conditions